Holden Comprehensive Cancer Center Research Executive Committee

Chair: Michael D. Henry, PhD


Bryan G. Allen, MBA, MD, PhD

  • Department Chair
  • Associate Professor

Gail A. Bishop, PhD

  • Associate Director of Basic Research for Holden Comprehensive Cancer Center
  • Professor

Marisa R. Buchakjian, MD, PhD, FACS

  • Emerging Leaders Council (ELC) Chair, Holden Comprehensive Cancer Center
  • Director of Translational Head and Neck Cancer Research
  • Assistant Professor

Elizabeth Chrischilles, PhD

  • Associate Director for Population Science
  • Department of Epidemiology Chair
  • Pomerantz Chair in Public Health
  • Health Effectiveness Research Center Director
  • Professor

Michael D. Henry, PhD

  • Interim Director for Holden Comprehensive Cancer Center
  • Professor
  • Department: Molecular Physiology and Biophysics, Pathology, Urology, Radiation Oncology, Internal Medicine
  • Program: Program 1: Cancer Genes and Pathways (CGP)
  • Membership Status: Full Member
  • Holden Leadership Role: Interim Director for Holden Comprehensive Cancer Center

Richard M. Hoffman, MD, MPH

  • Professor Emeritus

Jon C. Houtman, PhD

  • Associate Director of Career Enhancement at Holden Comprehensive Cancer Center
  • Professor

Yusuf Menda, MD

  • Professor

Mohammed M. Milhem, MBBS

  • Holden Chair of Experimental Therapeutics
  • Melanoma Program Director at Holden Comprehensive Cancer Center
  • Director-Division of Hematology, Oncology, and Blood & Marrow Transplantation
  • Clinical Professor

Dawn E. Quelle, PhD

  • Professor

Aliasger K. Salem, PhD

  • Associate Vice President for Research, University of Iowa
  • Bighley Professor of Pharmaceutical Sciences

Aaron Seaman, PhD

  • Assistant Professor

Andrean L. Simons-Burnett, PhD

  • Associate Director of Diversity, Equity and Inclusion (DEI)
  • Holden Comprehensive Cancer Center Diversity Task Force Chair
  • Associate Professor

Douglas R. Spitz, Jr., PhD

  • Professor

George J. Weiner, MD

  • Director Emeritus for Holden Comprehensive Cancer Center
  • Professor
  • Department: Pharmaceutical Sciences and Experimental Therapeutics, Internal Medicine
  • Program: Program 2: Experimental Therapeutics (ET)
  • Membership Status: Full Member
  • Holden Leadership Role: Director Emeritus for Holden Comprehensive Cancer Center